Hallwang Clinic GmbH

What Hallwang Clinic GmbH does

Hallwang Clinic GmbH is a privately held, single-site oncology clinic located in Dornstetten/Hallwangen in the Black Forest of Southern Germany, operating since 2009. The clinic delivers individualized cancer treatment anchored in immunotherapy, offering conventional chemotherapy, monoclonal antibody regimens (rituximab, alemtuzumab, trastuzumab, bevacizumab, cetuximab), and checkpoint inhibitor therapies targeting CTLA-4 and PD-1/PDL-1. It supports treatment selection through Next-Generation Sequencing and Tumor-Associated Antigen (TAA) Screening to identify patient-specific mutations and antigens.

The clinic operates as a destination medical facility serving international cancer patients, with documented patient origin spanning Australia, the USA, and Europe, and case profiles frequently involving advanced disease where patients have been told to go home and die by other healthcare systems. Patients are admitted for inpatient care with 24/7 medical coverage, physiotherapy, and professional psychological support; off-site CT, MRI, PET, and radiotherapy services are arranged through partner clinics. The clinic's go-to-market relies on direct inbound interest from patients and referring ecosystems, supplemented by a Facebook page and an official blog (hallwang-clinic.blogspot.com) that publishes patient stories and clinic updates. The clinic generates revenue through private-pay treatment packages (pricing not publicly disclosed), with no institutional funding, parent company, or public ownership disclosed.

Name

Hallwang Clinic GmbH

Legal name

Hallwang Clinic GmbH

Website

https://hallwang-clinic.blogspot.de

Company type

Private

Founded year

2009

Operating status

Operating

Short description

Hallwang Clinic GmbH is a privately held, single-site oncology clinic in Germany's Black Forest delivering individualized cancer immunotherapy, antibody therapy, and chemotherapy, supported by NGS diagnostics and TAA screening for international patients.

Ownership category

akta.pro rank

Product category

Private Oncology Care

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Medical Oncology (HLAKAFAB)

Keywords

• Cancer immunotherapy
• Oncology diagnostics
• Monoclonal antibody therapy
• Precision oncology
• Private oncology clinic

Headquarters

HQ city

Dornstetten

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Distribution channels1 record

Marketing channels2 records

Core offering

Hallwang Clinic GmbH is a private oncology clinic in Southern Germany's Black Forest (Dornstetten/Hallwangen) that delivers individualized cancer treatment strategies, including conventional chemotherapy, monoclonal antibody treatments, and patient-specific cancer immunotherapy. The clinic supplements treatment with advanced diagnostics such as Next-Generation Sequencing (NGS) and Tumor-Associated Antigen (TAA) screening, and coordinates imaging (CT, MRI, PET) and radiotherapy through partner clinics.

Product overview

Hallwang Clinic GmbH is a private oncology clinic offering a comprehensive range of cancer treatment services. The clinic provides conventional chemotherapy, antibody treatments, and individualized immunotherapy as its core treatment offerings. Supporting these treatments, the clinic offers cutting-edge diagnostics including Next-Generation Sequencing and Tumor-Associated Antigen (TAA) Screening to identify personalized treatment targets. Additional supportive services include coordinated diagnostic imaging (CT, MRI, PET scans), radiotherapy coordination, physiotherapy, psychological support, and 24/7 medical care. The clinic serves international patients and is located in the Black Forest region of Southern Germany.

Differentiator

Problem solved

Functional benefit

Products and services

• Cancer Immunotherapy (Individualized) Patient-tailored immune-based cancer treatment for international oncology patients, especially those seeking alternatives beyond standard protocols.
• Conventional Chemotherapy Standard-of-care chemotherapy administered to cancer patients as part of individualized treatment plans.
• Monoclonal Antibody Treatments Targeted antibody-based cancer therapies delivered to oncology patients as part of personalized treatment strategies.
• Next-Generation Sequencing (NGS) Diagnostics Molecular diagnostic testing using next-generation sequencing to characterize tumors and inform personalized therapy selection.
• Tumor-Associated Antigen (TAA) Screening Diagnostic screening for tumor-associated antigens to identify targets for individualized immunotherapy.
• Coordinated Diagnostic Imaging Coordination of CT, MRI, and PET imaging scans through partner facilities to support cancer diagnosis and treatment monitoring.
• Coordinated Radiotherapy Radiotherapy arranged through partner clinics as part of comprehensive cancer treatment plans.
• Physiotherapy and Psychological Support Adjunct supportive services including physiotherapy and psychological counseling for cancer patients during treatment.
• 24/7 Medical Care Continuous around-the-clock medical supervision and care for admitted oncology patients.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered supportive.

• Various Medical Clinics (Diagnostics)supportiveStrategic or Co-development PartnerHallwang Clinic collaborates with many other medical clinics to provide further diagnostics such as CT, MRI, and PET scans. These partnerships enable comprehensive diagnostic capabilities beyond what is available on-site.
• Radiotherapy ProviderssupportiveStrategic or Co-development PartnerHallwang Clinic can organize radiotherapy through partner facilities should that be necessary for patient treatment plans.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Direct peers

• Arcadia Praxisklinik: Private specialty clinic in Germany offering integrative and individualized cancer treatment, including complementary and alternative oncology approaches. Comparable positioning to Hallwang as a destination private oncology clinic.
• CHIPSA Hospital: Mexican private hospital specializing in integrative and immunologically-based cancer treatment for international patients. Closest substitute destination for patients who would otherwise consider a German private clinic like Hallwang.
• Hope4Cancer Treatment Centers: Mexico-headquartered network of private cancer clinics offering integrative and immunotherapy protocols to international patients. Comparable to Hallwang in serving self-pay medical-tourism cancer patients.
• Burzynski Clinic: US-based private clinic offering personalized, non-conventional cancer treatments. Most internationally comparable peer to Hallwang in positioning as a destination clinic for late-stage patients seeking alternative oncology care.
• Biomed Klinik Bad Bergzabern: Private hospital in southwestern Germany focused on integrative oncology, including immunomodulatory and complementary cancer therapies. Overlaps with Hallwang in offering personalized, non-conventional cancer treatment in a small-clinic setting.
• IOZK – Immuno-Oncological Centre Cologne: German private clinic in Cologne focused on immuno-oncology and personalized cancer therapies. Direct competitor to Hallwang in the German private immunotherapy market, serving patients who have exhausted standard-of-care options.
• Veramed Klinik am Ring: Private oncology clinic in Germany offering individualized multimodal cancer treatment. Targets international patients seeking alternatives to standard hospital oncology, directly comparable to Hallwang's positioning.
• Aeskulap Klinik Brunnen: Swiss private clinic offering complementary and integrative oncology within a German-speaking environment. Comparable European private oncology clinic serving self-pay patients seeking alternative cancer treatment.

Broad incumbents

• Charité Comprehensive Cancer Center: Major university cancer center in Berlin offering full-spectrum academic oncology including advanced immunotherapy, NGS diagnostics, and clinical trials. Represents the institutional alternative that some Hallwang patient candidates consider and against which Hallwang differentiates on personalization.
• National Center for Tumor Diseases (NCT) Heidelberg: Leading German academic oncology center offering precision oncology, immunotherapy, and molecular diagnostics within the national healthcare system. Geographic and clinical benchmark for Hallwang on medical-oncology practice in Southern Germany.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key highlights6 records

Customer concentration

• Facebookde-de.facebook.com/Hallwang-Private-Oncology-Clinic-414100488682843
• Xx.com/HallwangClinic

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hallwang Clinic GmbH